arrow
Y

Yoshikane Kikushige

kyushu university hospital
H指数:28
被引数:3,661

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimal levetiracetam dosage regimen for preventing seizures related to immune effector cell-associated neurotoxicity syndrome

预防免疫效应细胞相关神经毒性综合征相关癫痫的最优左乙拉西坦给药方案

2026-11-140
PRE
Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial

日本急性早幼粒细胞白血病前线ATRA-ATO疗法:来自前瞻性多中心FBMTG-APL2017试验的结果

2026-01-210
OA
Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL

PD-1阻断治疗后复发或难治性PMBCL患者中lisocabtagene maraleucel的安全性与有效性

2026-01-010
PRE
Comparison of quantitative PCR values and antigenemia for CMV monitoring in hematopoietic cell transplant recipients

定量PCR值与抗原血症在造血细胞移植受者CMV监测中的比较

2025-12-010
PRE
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells

鸟嘌呤核苷酸驱动急性髓系白血病干细胞中的核糖体生物发生和糖酵解重编程

Blood
IF23.1
2025-11-070
OAAI
Engraftment syndrome after PD-1 blockade in classical Hodgkin lymphoma treated by autologous stem cell transplantation

自体干细胞移植治疗经典霍奇金淋巴瘤PD-1阻滞后植入综合征

2025-10-011
OAAI
Objective quantification of pre-CAR-T EEG abnormalities for ICANS prognosis: insights from GTE scoring

预CAR-T EEG异常的客观量化及其对ICANS预后的影响:GTE评分的见解

2025-04-280
PRE
Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy

脑脊液蛋白质组学对嵌合抗原受体T细胞疗法相关的免疫效应细胞神经毒性综合征(ICANS)具有预测潜力。

LEUKEMIA
IF13.4
2025-03-110
OAAI